UltraGreen.ai Limited (ULG) said on May, 5 2026 that it has received regulatory approval in Singapore for Verdye, its indocyanine green injection used in fluorescence-guided surgery.
The green light in Singapore, a key medical hub for the region, supports the company’s strategy to expand access to fluorescence-guided procedures across Southeast Asia. Verdye is now cleared in 41 countries.
With the approval, UltraGreen.ai plans to deepen collaborations with Singaporean healthcare institutions and accelerate commercial rollout of its integrated platform, which combines pharmaceutical agents, imaging hardware and AI-based data tools.
The company noted that its IC-Flow imaging system is authorised in 45 markets worldwide. The latest milestone follows its recent initial public offering and Verdye’s clearance in the Philippines.
UltraGreen.ai, headquartered in Singapore with operations in the United States, Ireland and other Asia-Pacific locations, develops fluorescence imaging solutions aimed at enhancing surgical precision. For additional details, visit the company’s website.